When comparing IDH1 and IDH2 subtypes, median log10 fold reduction was 1.63 for IDH1 and 1.35 for IDH2 (p = 0.2317), while the median rate of blast reduction was 4.5% versus 4% log10/day (p = 0.1429), respectively, indicating comparable magnitude and kinetics of blast clearance between IDH1‐ and IDH2‐mutated AML (Figures S13 and S14). Here, IDH2 is linked to acute myeloid leukemia.